Selective identification of Valpha14i T cells using slide-immobilized, CD1d-antigen complexes
Alfred J Zullo1, Randy R Brutkiewicz, Elizabeth J Taparowsky
1Department of Biological Sciences and Purdue Cancer Center, Purdue University, West Lafayette, Indiana 47907-2054, USA.
Journal of Immunoassay & Immunochemistry
|July 11, 2006
Summary
Researchers developed a novel CD1-antigen array to detect antigen-reactive lymphocytes, specifically CD1-restricted T cells, which are crucial for understanding and combating diseases. This technique advances diagnostic strategies by enabling the profiling of biological samples.
Area of Science:
- Immunology
- Biotechnology
- Molecular Biology
Background:
- Correlating antigen-reactive lymphocytes with disease is key for developing therapeutic strategies.
- CD1-restricted T cells represent a critical lymphocyte subset for immune response.
- Current methods lack efficient ways to query CD1-restricted lymphocytes in humans.
Purpose of the Study:
- To investigate the feasibility of using CD1 molecules in an array format to detect CD1-restricted lymphocytes.
- To establish a foundation for CD1-antigen arrays for biological sample profiling.
Main Methods:
- Utilized mouse CD1d (mCD1d) and alpha-galactosylceramide (alpha-GalCer).
- Created slide-immobilized CD1d-alpha-GalCer complexes.
- Tested the capture of NKT cell hybridoma in the presence of a competitor.
Main Results:
- Demonstrated successful capture of an NKT cell hybridoma using immobilized CD1d-alpha-GalCer complexes.
- Confirmed the specificity of the capture in the presence of competing molecules.
- Validated the feasibility of the CD1-antigen array approach.
Conclusions:
- The developed CD1-antigen array system is a viable first step towards advanced diagnostic tools.
- This technique could enable the profiling of biological samples for immune cell detection.
- Further development of CD1-antigen arrays holds promise for disease research and treatment strategies.
